US$ 20.89
generic glp-1 agonist There's still no Ozempic, but a lower-priced daily injected is coming PDB-101: Molecule of the Month:
Description
[DOI] [PubMed] [Google Scholar] 42.Schmitt C, Portron A, Jadidi S, Sarkar N & DiMarchi R Pharmacodynamics, pharmacokinetics and safety of multiple ascending doses of the novel dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 agonist RG7697 in people with type 2 diabetes mellitus

doi: 10.3390/ijms22020860 [DOI] [PMC free article] [PubMed] [Google Scholar] 148

Adv Exp Med Biol (2019) 1184:187203

Yi B, Hu X, Wen Z, Zhang T, Cai Y

S.GomisR.HanefeldM.et al

Ding WG, Gromada J